Log In
Print this Print this

faster-acting insulin aspart, FIAsp (NN1218)

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionFaster-acting insulin aspart formulation
Molecular Target Insulin receptor (INSR)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentRegistration
Standard IndicationDiabetes
Indication DetailsTreat Type I and II diabetes; Treat Type I diabetes; Treat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today